Thorac Cardiovasc Surg 2000; 48(5): 269-273
DOI: 10.1055/s-2000-7882
Original Cardiovascular
ORIGINALARBEIT
© Georg Thieme Verlag Stuttgart · New York

Complete Arterial Revascularization Using T-Graft Technique in Diabetics with Coronary Three-Vessel Disease

Functional and Morphological Results in the Early Postoperative Period[*] T. Markwirth1 , B. Hennen1 , B. Scheller1 , N.-J. Schäfers2 , O. Wendler2
  • 1Medizinische Klinik III (Kardiologie/Angiologie) Universitätskliniken des Saarlandes, Homburg/Saar, Germany
  • 2Abteilung für Thorax- und Herz-Gefäßchirurgie Universitätskliniken des Saarlandes, Homburg/Saar, Germany
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Background: Coronary revascularization using exclusively arterial grafts holds the promise of improved long-term patency. The T-graft approach achieves this goal with only two arterial grafts in coronary 3-vessel disease. Arterial grafts in diabetics, however, exhibit more frequently atherosclerotic wall abnormalities, and higher levels of endothelin-1 were found in diabetic arterial grafts, which may be associated with a higher incidence of vasoconstriction. The objective of this prospective study was to compare functional und angiographic parameters of arterial T-grafts in diabetics and nondiabetics. Methods: Coronary angiography was performed consecutively in 20 patients with insulin-dependent diabetes mellitus (IDDM), 20 patients with non-insulin-dependent diabetes mellitus (NIDDM), and 100 non-diabetics one week after complete arterial revascularization with T-grafts. Graft patency was assessed, and the diameter of the proximal left internal mammary artery (IMA) graft was measured using quantitative coronary analysis. Absolute flow volume in the proximal left IMA was measured using the flow-wire technique at baseline and after an adenosine injection into the graft to induce maximal hyperemia. Coronary flow reserve (CFR) was calculated as the ratio of maximal to baseline flow. Results: There was no difference between patients with IDDM, patients with NIDDM and non-diabetics with respect to patency (98.3 % vs. 98.8 % vs. 97,8 %, n. s.), graft lumen diameter (3.42 ± 0.48 vs. 3.36 ± 0.50 vs. 3.38 ± 0.41 mm, n. s.), baseline flow (78.4 ± 34.3 vs. 83.1 ± 36.6 vs. 81.5 ± 39.0 ml/min, n. s.), and CFR (1.85 ± 0.37 vs. 1.89 ± 0.44 vs.1.90 ± 0.40, n. s.). Conclusion: Baseline parameters (graft diameter and quantitative graft flow), patency and CFR are identical in diabetics and non-diabetics. Our results suggest that diabetic patients with coronary 3-vessel disease take comparable profit from complete arterial revascularization using the T-graft technique as non-diabetics.

1 The paper was presented at the 3rd Joint Meeting of the German, the Austrian and the Swiss Societies for Thoracic and Cardiovascular Surgery in Luzern, February 9 - 12, 2000

References

  • 1 Grondin C M, Campeau L, Lesperance J, Enjalbert M, Bourassa M G. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation.  Circulation. 1984;  70 208-212
  • 2 Loop F D, Lytle B W, Cosgrove D M. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.  N Engl J Med. 1986;  314 1-6
  • 3 Cameron A, Kemp H G, Green G E. Bypass surgery with the internal mammary artery graft: 15 year follow-up.  Circulation. 1986;  74 Suppl. III:III 30-36
  • 4 Fiore A C, Naunheim K S, Dean P, Kaiser G C, Pennington G, Willman V L. Results of internal thoracic artery grafting over 15 years: single versus double grafts.  Ann Thorac Surg. 1990;  49 202-209
  • 5 Dewar L R S, Jamieson E, Janusz M T, Adeli-Sardo M, Germann E, Mac Nab J S. Unilateral versus bilateral internal mammary revascularization.  Circulation. 1995;  92 (supp) II8-13
  • 6 Pick A W, Orszulak T W, Anderson B, Schaff H V. Single versus bilateral internal mammary artery grafts: 10-year outcome analysis.  Ann Thorac Surg. 1997;  64 599-605
  • 7 Tector A J, Amundsen S, Schmahl T M, Kress D C, Peter M. Total revascularization with T-Grafts.  Ann Thorac Surg. 1994;  57 33-39
  • 8 Acar C, Jebara V A, Portoghese M, Beyssen B, Pagny J Y, Grare P. Revival of the radial artery for coronary artery bypass grafting.  Ann Thorac Surg. 1992;  54 652-660
  • 9 Calafiore A M, Giammarco G D, Luciani N, Maddestra N, Nardo E D, Angelini R. Composite arterial conduits for a wider arterial myocardial revascularization.  Ann Thorac Surg. 1994;  58 185-190
  • 10 Barner H B. Arterial grafting: techniques and conduits.  Ann Thorac Surg. 1998;  66 S2-5
  • 11 Julien J. Cardiac complications in non-insulin-dependent diabetes mellitus.  J Diabetes Complications. 1997;  11:2 123-130
  • 12 Kaufer E, Factor S M, Frame R, Brodman R F. Pathology of the radial and internal thoracic arteries used as coronary artery bypass grafts.  Ann Thorac Surg. 1997;  63:4 1118-1122
  • 13 Wendler O, Hennen B, Markwirth T. et al . T-grafts with the right internal thoracic artery to left internal thoracic artery vesus the left internal thoracic artery and radial artery: flow dynamics in the internal thoracic artery main stem.  J Thorac Cardiovasc Surg. 1999;  118 841-848
  • 14 Doucette J W, Corl D, Payne H. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velofity.  Circulation. 1992;  85 1899-1911
  • 15 Del Rizzo D F, Fremes S E, Christakis G T. The current status of myocardial revascularization: changing trends and risk factors.  J Card Surg. 1996;  11 18-29
  • 16 Hennen B, Markwirth T, Scheller B, Schäfers H J, Wendler O. Do changes in blood flow in the subclavian artery affect flow volume and flow dynamics in IMA grafts in patients who have undergone complete arterial revascularization with the T-graft technique?. Thorac Cardiovasc Surg 2000 in press
  • 17 Wendler O, Hennen B, Warkwirth T, Nikolouidakis N, Graeter T, Schäfers H J. Complete arterial revascularization in the diabetic patient. Thorac Cardiovasc Surg 2000 in press
  • 18 Sueda T, Shikata H, Orihashi K, Kanehiro K, Kauwaue Y, Matsuura Y. Morphological comparison between arterial and veneous grafts.  Nippon Kyobu Geka Gakkai Zasshi. 1994;  42 (9) 1315-1319
  • 19 Göbel H, Ihling C, Dentz J, Schaefer H E, Zeiher A M, Fraedrich G. Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterinemia modulates the graft flow in the per-operative period.  Eur J Cardiothorac Surg. 1998;  14(4) 367-372
  • 20 Gurne O, Chenu P, Polidori C. et al . Functional evaluation of internal mammary artery bypass grafts in the early and late postoperative periods.  JACC. 1995;  25 (5) 1120-1128
  • 21 Akasaka T, Yoshikawa J, Yoshida K. et al . Flow capacity of internal mammary artery grafts: early restriction and later improvement assessed by Doppler guide wire.  JACC. 1995;  25(3) 640-647
  • 22 Triana J F, Bolli R. Decresead flow reserve in “stunned” myocardium after a 10-min coronary occlusion.  Am J Physiol. 1991;  Sep 261:3 Pt2 H793-804

1 The paper was presented at the 3rd Joint Meeting of the German, the Austrian and the Swiss Societies for Thoracic and Cardiovascular Surgery in Luzern, February 9 - 12, 2000

Dr. med. T. Markwirth

Medizinischc Klinik III (Kardiologie/Angiologie) Universitätskliniken des Saarlandes

Kirrberger Strasse 1

66421 Homburg/Saar

Germany

Phone: 0049 6841 163364

Fax: 0049 6841 163385

Email: inmark@med-rz.uni-sb.de

    >